Boston Scientific rises after Q1 results beat, FY forecast raise
View all comments(0)
Shares of medical device maker Boston Scientific BSX.N rise 4.4% to $99.24 premarket
Co reports Q1 adjusted profit of 75 cents per share, topping analysts' estimates of 67 cents per share, according to estimates compiled by LSEG
Q1 revenue came in at $4.66 billion vs estimates of $4.57 billion
BSX raises 2025 adjusted EPS forecast to $2.87-$2.94 from $2.80-$2.87 per share
Analysts were expecting a profit of $2.86 per share for the year -LSEG
Up to last close, BSX shares rose 6.4% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.